Table 2.

Relationship of clinicopathological features with CTA‐941F9.9 expression in cohort 2 tissue samples of colorectal cancer

Characteristics	Number of patients (%)	CTA‐941F9.9 expression levela	P‐Value
Age
Maximum‐Minimum (29‐86)	59 (100.0)	0.073 (0.032‐0.279)	.704
Gender
Male	31 (52.5)	0.056 (0.031‐0.279)	.242
Female	28 (47.5)	0.092 (0.039‐0.394)
Tumor location
Colon	26 (44.1)	0.083 (0.031‐0.280)	1.000
Rectum	33 (55.9)	0.066 (0.031‐0.304)
Tumor size
Maximum‐Minimum (2.3‐12.0 cm)	59 (100.0)	0.073 (0.032‐0.279)	.443
Histological grade
Well	11 (18.6)	0.081 (0.017‐0.178)	.149
Moderately	42 (71.2)	0.065 (0.031‐0.280)
Poorly	6 (10.2)	0.384 (0.063‐1.097)
pT stage
T2	5 (8.5)	0.017 (0.011‐0.330)	.351
T3	19 (33.2)	0.187 (0.032‐0.330)
T4	35 (59.3)	0.060 (0.033‐0.264)
pN stage
0	32 (54.2)	0.068 (0.020‐0.253)	.420
1	17 (28.8)	0.134 (0.057‐0.435)
2	10 (16.9)	0.055 (0.025‐0.643)
pTNM stage
1	5 (8.4)	0.017 (0.011‐0.330)	.581
2	27 (45.8)	0.073 (0.032‐0.266)
3	23 (39.0)	0.118 (0.047‐0.435)
4	4 (6.8)	0049 (0.032‐0.808)

^aMedian relative expression (25th‐75th percentile).